Table 3.
The results of antibiotic treatment of each cell line
No* | Cell line name | Cell type | NCBI code | Pla | BM | MRA | Cip | Curing antibiotic | Mycoplasma species |
---|---|---|---|---|---|---|---|---|---|
1 | MCF-7 | Human breast Adeno carcinoma | C135 | Ο | Ο | Ο | ∆ | Pla, BM, MRA | Mhy |
2 | T-47D | Human breast ductal carcinoma | C203 | Ο | Ο | ∆ | ∆ | Pla, BM | Mfe |
3 | RAJI | Human Burkitt’s lymphoma | C127 | Ο | X | X | ∆ | Pla | Mfe |
4 | NSO | Mouse myeloma | C142 | Ο | X | Ο | Ο | Pla, MRA, Cip | Mfe |
5 | HEP G2 | Human hepatocyte carcinoma | C158 | Ο | Ο | X | ∆ | Pla, BM | Mhy |
6 | A-431 | Human squamous carcinoma | C204 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mhy |
7 | HFFF-PI6 | Human fetal foreskin fibroblast | C170 | X | Ο | ∆ | ∆ | BM | Mor |
8 | Hep2 | Human Larynx carcinoma | C144 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy |
9 | MRC-5 | Human foetal lung fibroblast | C125 | X | Ο | Ο | Ο | BM, MRA, Cip | Mar |
10 | Saos-2 | Human osteogenic sarcoma | C453 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mfe, Mhy |
11 | McCoy | Synovial tissue fibroblast | C123 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar |
12 | CCRF-CEM | Human Acute lymphoblastic leukemia | C105 | X | Ο | Ο | Ο | BM, MRA, Cip | Mfe |
13 | PANC-1 | Human pancreas duct epithelial carcinoma | C556 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar, Mfe, Mhy |
14 | B95-8 | Marmoset EBV transformed lymphocytes | C110 | ∆ | Ο | ∆ | ∆ | BM | Mar, Mfe |
15 | CHO | Chinese hamster ovary | C111 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mar |
16 | DAUDI | Human Burkitt’s lymphoma | C112 | X | Ο | ∆ | ∆ | BM | Mor |
17 | BT-474 | Human breast ductal carcinoma | C435 | Ο | Ο | Ο | ∆ | Pla, BM, MRA | Mar |
18 | JIYOYE | Human Burkitt’s lymphoma | C117 | Ο | X | Ο | ∆ | Pla, MRA | Mor |
19 | MDA-MB-468 | Human breast adenocarcinoma | C208 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mfe, Mhy |
20 | HUT-78 | Human cutaneus T cell lymphoma | C185 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar, Mfe, Ala |
21 | J774A.1 | Mouse monocyte/macrophage | C483 | ∆ | ∆ | ∆ | ∆ | Mar, Mhy | |
22 | LNCap-FGC-10 | Human prostate cancer | C439 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy |
23 | F3B6 | Human × mouse heterohybridoma | C197 | X | X | ∆ | ∆ | Mar, Mor | |
24 | SP2/0-Ag14 | Mouse myeloma | C129 | ∆ | Ο | ∆ | ∆ | BM | Mfe, Mhy |
25 | Vero | African Green Monkey Kidney | C101 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar, Mfe, Mhy |
26 | K562 | Human CML | C122 | Ο | Ο | ∆ | ∆ | Pla, BM | Ala |
27 | WEHI-164 | Mouse BALB/c fibrosarcoma | C200 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy |
28 | BCL1 clone 5B1b | Mouse lymphoma | C551 | X | X | Ο | Ο | MRA, Cip | Ala |
29 | SK-N-MC | Human neuroblastoma | C535 | Ο | ∆ | ∆ | ∆ | Pla | Mfe |
30 | BW5147 | Mouse thymoma | C542 | X | Ο | X | ∆ | BM | Mhy |
31 | STO | Mouse SIM fetal fibroblast | C537 | ∆ | Ο | ∆ | ∆ | BM | Mhy |
32 | CT26 | Mouse colon carcinoma | C532 | ∆ | Ο | ∆ | ∆ | BM | Mhy |
33 | THP-1 | Human acute Monocytic leukemia | C563 | Ο | Ο | ∆ | ∆ | Pla, BM | Mor |
34 | PC12 | Rat adrenal fibroblast pheochromocytoma | C153 | ∆ | Ο | ∆ | ∆ | BM | Mhy |
35 | Seraphina | Human Burkitt’s lymphoma | C102 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mfe |
36 | LCL-PI 12 | Human EBV transformed cord blood B cell | C178 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mfe |
37 | HGF3-PI 53 | Human gingival fibroblast | C502 | X | Ο | ∆ | ∆ | BM | Mhy |
38 | HSF-PI 17 | Human skin fibroblast | C193 | X | Ο | X | ∆ | BM | Mfe |
39 | B65 | Rat nervous tissue neuronal tumor | C134 | X | X | Ο | ∆ | MRA | Mar |
40 | P3X63Ag8.653 | Mouse-myeloma | C109 | X | X | ∆ | ∆ | Mar | |
41 | Hela | Human cervix carcinoma | C115 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mfe, Mhy |
42 | U937 | Human Histiocytic lymphoma | C130 | Ο | Ο | ∆ | ∆ | Pla, BM | Mfe |
43 | Hek293 | Human embryonic kidney cells | C497 | ∆ | Ο | ∆ | ∆ | BM | Mhy |
44 | HL60 | Human promyelocytic leukemia | C217 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar, Msa |
45 | SKBR3 | Human breast adenocarcinoma | C207 | Ο | ∆ | ∆ | ∆ | Pla | Mor, Mhy |
46 | Peer | Human acute T cell lymphoblastic leukemia | C511 | X | Ο | X | Ο | BM, Cip | Ala |
47 | HL60/mix 1 | Human acute promyelocytic leukemia | C553 | X | Ο | ∆ | ∆ | BM | Mar, Mpi |
48 | HPA/ALL | Human T cell acute lymphoblastic leukemia | C213 | X | X | X | Ο | Cip | Mfe |
49 | MG63 | Human osteosarcoma | C555 | Ο | Ο | Ο | ∆ | Pla, BM, MRA | Mar |
50 | LB3.1 (HB-298) | Mouse anti human HLA-DR alpha chain hybridoma | H195 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mhy, Mho |
51 | NIH3T3 | Mouse Swiss embryo fibroblast | C156 | Ο | Ο | Ο | ∆ | Pla, BM, MRA | Mhy |
52 | Caco2 | Human colon adenocarcinoma | C139 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mhy |
53 | CoR-L-105 | Human lung adenocarcinoma | C113 | Ο | Ο | ∆ | ∆ | Pla, BM | Mor |
54 | L929 | Mouse connective tissue fibroblast | C161 | Ο | Ο | ∆ | ∆ | Pla, BM | Mfe |
55 | A3.6B10 (HB-12318) | Mouse anti human CTLA-4 (CD152) hybridoma | H196 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mhy, Mho |
56 | Nalm6 | Pre B cell leukemia | C212 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mfe |
57 | KG1 | Human Caucasian bone marrow myeloid leukemia | C119 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Msa |
58 | T45 | Human T cell acute lymphoblastic leukemia | C180 | X | X | Ο | ∆ | MRA | Mpi |
59 | PC3 | Human prostate adenocarcinoma | C427 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy |
60 | MDA-MB231 | Human breast adenocarcinoma | C578 | Ο | Ο | ∆ | ∆ | Pla, BM | Mar |
61 | CHO DG-44 | Dihydrofolate reductase-deficient CHO | C576 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mar |
62 | PC12 (Suspension) | Rat adrenal pheochromocytoma | C189 | X | ∆ | Ο | ∆ | MRA | Mhy |
63 | G28 | Mouse anti human CD40 hybridoma | H150 | ∆ | X | Ο | ∆ | MRA | Mar, Mhy, Msa |
64 | NS1 | Mouse myeloma | C522 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mhy |
65 | MDBK | Bovine normal kidney epithelial cells | C500 | Ο | X | ∆ | ∆ | Pla | Mar, Mhy |
66 | Rael | Human Burkitt’s lymphoma | C186 | Ο | X | ∆ | ∆ | Pla | Mor |
67 | DFW | Human melanoma | C496 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mfe |
68 | LCL PI7 | Human EBV-transformed peripheral blood B cells | C175 | Ο | Ο | Ο | ∆ | Pla, BM, MRA | Mfe |
69 | B16F10 | Mouse melanoma | C540 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mfe, Mhy |
70 | ASPC1 | Human pancreas adenocarcinoma | C558 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy, Mpi |
71 | HT29 | Human colon adenocarcinoma | C466 | Ο | Ο | ∆ | ∆ | Pla, BM | Mhy |
72 | LS180 | Human colon adenocarcinoma | C508 | X | Ο | Ο | ∆ | BM, MRA | Mar |
73 | A2780S | Human ovarian carcinoma (sensitive to Cisplatin) | C461 | Ο | X | Ο | ∆ | Pla, MRA | Mhy |
74 | MOLT-17 | Human T cell leukemia | C516 | Ο | Ο | Ο | Ο | Pla, BM, MRA, Cip | Mfe |
75 | CAOV-4 | Human ovary adenocarcinoma | C595 | Ο | Ο | ∆ | ∆ | Pla, BM | Mfe,Mge |
76 | DND-41 | Human T cell acute lymphoblastic leukemia | C183 | X | Ο | X | ∆ | BM | Mor |
77 | RPMI 8402 | Human T cell acute lymphoblastic leukemia | C184 | Ο | X | X | Ο | Pla, Cip | Mfe |
78 | LL/2(LLC1) | Mouse Lewis lung carcinoma | C587 | Ο | ∆ | ∆ | ∆ | Pla | Mar, Mhy, Ala |
79 | BHK21-2PCLone13 | Baby hamster kidney from Syrian hamster (suspension culture) | C108 | X | Ο | ∆ | ∆ | BM | Mar, Mfe |
80 | HFIF PI4 | Human fetal liver fibroblast | C168 | X | Ο | ∆ | ∆ | BM | Mfe, Mhy, Uur |
Ο, cured; ∆, regrowth; X, culture death; Pla, Plasmocin™; BM, BM-cyclin; Cip, Ciprofloxacin; NCBI, National Cell Bank of Iran; Mar, M. arginini; Mfe, M. fermentans; Mor, M. orale; Mhy, M. hyorhinis; Ala, A. laidlawii; Msa, M. salivarium; Mpi, M. pirum; Mho, M. hominis; Mge, M. genitalium; Uur, U. urealyticum; (−), non-detected mycoplasma species; (+), detected species-specific mycoplasma